Arbutus presents ab-343 data at the 36th international conference on antiviral research

Antiviral potency, selectivity and favorable pk support further development of ab-343 as potential ritonavir-free oral treatment for covid-19 and other human coronaviruses
ABUS Ratings Summary
ABUS Quant Ranking